Measurement of activated factor XII in health and disease

R. Coppola, P. Cristilli, M. Cugno, R. A S Ariëns, D. Mari, P. M. Mannucci

Research output: Contribution to journalArticle

Abstract

We investigated a new ELISA for measuring activated factor XII (FXIIa) in plasma. The intra-assay coefficient of variation was 3.5% and 5.1% for plasma containing 2.5 and 8.2 ng/ml FXIIa. The inter-assay coefficient of variation was 6.2% and 6.6%. FXIIa correlated with age in women older than 55 years (r = 0.55, P = 0.0003). Mean levels in the whole population of 160 healthy individuals included in this study were not different between men and women, but women younger than 55 years had lower levels than older women and men of the corresponding age. In a group of 25 healthy centenarians FXIIa was significantly higher (3.2 ng/ml, 95% CI 2.3-3.6) than in controls (2.1 ng/ml, 95% CI 1.8-2.4). Increased levels were also found in pregnancy, with higher levels in the third trimester (4.7 ng/ml, 95% CI 3.9-5.5) than in the first trimester (2.9 ng/ml, 95% CI 2.2-3.9). FXIIa was unmeasurable in patients with FXII deficiency, but normal in patients with FXI deficiency and C1-inhibitor deficiency. FXIIa was significantly higher than in normal controls in patients with severe sepsis (3.9 ng/ml, 95% CI 2.8-5.4) and septic shock (5.4 ng/ml, 95% CI 3.7-7.7). After treatment with thrombolytic agents; a marked increase of FXIIa was found in patients with myocardial infarction. In conclusion, the immunoassay of FXIIa permits to study more directly the contact phase of blood coagulation in situations in which the involvement of this system may play a pathophysiological role.

Original languageEnglish
Pages (from-to)530-535
Number of pages6
JournalBlood Coagulation and Fibrinolysis
Volume7
Issue number5
Publication statusPublished - 1996

Keywords

  • Aging
  • C1-inhibitor deficiency
  • Contact activation
  • Factor XII
  • Pregnancy
  • Sepsis
  • Thrombolysis

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Measurement of activated factor XII in health and disease'. Together they form a unique fingerprint.

  • Cite this

    Coppola, R., Cristilli, P., Cugno, M., Ariëns, R. A. S., Mari, D., & Mannucci, P. M. (1996). Measurement of activated factor XII in health and disease. Blood Coagulation and Fibrinolysis, 7(5), 530-535.